In brief, our first pan-cancer analysis of WDR62 suggested that WDR62 was overexpressed in multiple tumors and closely correlated with poor prognosis and immune regulation, contributing to understanding the oncogenic role of WDR62 across human tumors. Here, WDR62 is linked to cancer.